Prostaglandin production during growth of Candida albicans biofilms

References

1. Alem M. A., Douglas L. J. 2004; Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans . Antimicrob Agents Chemother 48:41–47 [CrossRef]
   [Google Scholar]
2. Baillie G. S., Douglas L. J. 1999a; Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol 310:644–656
   [Google Scholar]
3. Baillie G. S., Douglas L. J. 1999b; Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol 48:671–679 [CrossRef]
   [Google Scholar]
4. Chen H., Fujita M., Feng Q., Clardy J., Fink G. R. 2004; Tyrosol is a quorum-sensing molecule in Candida albicans . Proc Natl Acad Sci U S A 101:5048–5052 [CrossRef]
   [Google Scholar]
5. Costerton W., Veeh R., Shirtliff M., Pasmore M., Post C., Ehrlich G. 2003; The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 112:1466–1477 [CrossRef]
   [Google Scholar]
6. Dannhardt G., Kiefer W. 2001; Cyclooxygenase inhibitors – current status and future prospects. Eur J Med Chem 36:109–126 [CrossRef]
   [Google Scholar]
7. Domingue P. A., Sadhu K., Costerton J. W., Bartlett K., Chow A. W. 1991; The human vagina: normal flora considered as an in situ tissue-associated, adherent biofilm. Genitourin Med 67:226–231
   [Google Scholar]
8. Douglas L. J. 2003; Candida biofilms and their role in infection. Trends Microbiol 11:30–36 [CrossRef]
   [Google Scholar]
9. Harris S. G., Padilla J., Koumas L., Ray D., Phipps R. P. 2002; Prostaglandins as modulators of immunity. Trends Immunol 23:144–150 [CrossRef]
   [Google Scholar]
10. Hawser S. P., Douglas L. J. 1994; Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 62:915–921
    [Google Scholar]
11. Hornby J. M., Jensen E. C., Lisec A. D., Tasto J. J., Jahnke B., Shoemaker R., Dussault P., Nickerson K. W. 2001; Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol 67:2982–2992 [CrossRef]
    [Google Scholar]
12. Kalo-Klein A., Witkin S. S. 1990; Prostaglandin E2 enhances and gamma interferon inhibits germ tube formation in Candida albicans . Infect Immun 58:260–262
    [Google Scholar]
13. Lewis R. E., Lo H.-J., Raad I. I., Kontoyiannis D. P. 2002; Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growth. Antimicrob Agents Chemother 46:1153–1155 [CrossRef]
    [Google Scholar]
14. Lo H.-J., Kohler J. R., DiDomenico B., Loebenberg D., Cacciapuoti A., Fink G. R. 1997; Nonfilamentous C.albicans mutants are avirulent. Cell 90:939–949 [CrossRef]
    [Google Scholar]
15. Noverr M. C., Phare S. M., Toews G. B., Coffey M. J., Huffnagle G. B. 2001; Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect Immun 69:2957–2963 [CrossRef]
    [Google Scholar]
16. Noverr M. C., Toews G. B., Huffnagle G. B. 2002; Production of prostaglandins and leukotrienes by pathogenic fungi. Infect Immun 70:400–402 [CrossRef]
    [Google Scholar]
17. Noverr M. C., Erb-Downward J. R., Huffnagle G. B. 2003; Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin Microbiol Rev 16:517–533 [CrossRef]
    [Google Scholar]
18. Ramage G., VandeWalle K., Lopez-Ribot J. L., Wickes B. L. 2002; The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans . FEMS Microbiol Lett 214:95–100 [CrossRef]
    [Google Scholar]